Ana Regina Cabrera

Prof. Ana Regina Cabrera

Exercise Research Center, University of Arkansas, Fayetteville, Arkansas, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in Journal of Applied Physiology
Verified
Journal Article
Closed access
ACAna Regina Cabrera
Ana Regina Cabrera
JDJ. William Deaver
J. William Deaver
SLSeongkyun Lim
Seongkyun Lim
FSFrancielly Morena da Silva
Francielly Morena da Silva
ESEleanor R. Schrems
Eleanor R. Schrems
NGNicholas P. Greene
Nicholas P. Greene
Our study demonstrates biological-sex differences in phenotypic characteristics of cancer cachexia between male and female mice, whereby females display many common characteristics of cachexia (gonadal fat loss and hepatosplenomegaly), protein synthesis markers alterations, and common catabolic markers in skeletal muscle despite relatively preserved muscle mass in early-stage cachexia compared with males. Mechanisms of cancer cachexia appear to differ between sexes. Data suggest need to place onus of early cancer cachexia detection and treatment on nonmuscle tissues in females.

1 November 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
STStavroula Tsitkanou
Stavroula Tsitkanou
FSFrancielly Morena da Silva
Francielly Morena da Silva
ACAna Regina Cabrera
Ana Regina Cabrera
ESEleanor R. Schrems
Eleanor R. Schrems
RMRuqaiza Muhyudin
Ruqaiza Muhyudin
NGNicholas P. Greene
Nicholas P. Greene
Herein, we assess the efficacy of the mitochondria-targeted antioxidant SkQ1 to mitigate cancer cachexia (CC) in both biological sexes. We demonstrate that SkQ1 administration attenuates muscle wasting induced by C26 tumors in male, but not female, mice. Conversely, we identify that in females, SkQ1 improves muscle contractility. These phenotypic adaptations to SkQ1 are aligned with respective responses in muscle protein synthesis, mitochondrial respiration, and mRNA content of protein turnover, as well as mitochondrial and calcium handling-related markers.

1 August 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
FMFrancielly Morena
Francielly Morena
ACAna Regina Cabrera
Ana Regina Cabrera
NGNicholas P. Greene
Nicholas P. Greene
Cancer cachexia (CC) is a multifactorial and complex syndrome experienced by up to 80% of patients with cancer and implicated in ∼40% of cancer-related deaths. Given its significant impact on patients’ quality of life and prognosis, there has been a growing emphasis on elucidating the underlying mechanisms of CC using preclinical models. However, the mechanisms of cachexia appear to differ across several variables including tumor type and model and biologic variables such as sex. These differences may be exacerbated by variance in experimental approaches and data reporting. This review examines literature spanning from 2011 to March 2024, focusing on common preclinical models of CC, including Lewis Lung Carcinoma, pancreatic KPC, and colorectal colon-26 and Apcmin/+ models. Our analysis reveals considerable heterogeneity in phenotypic outcomes, and investigated mechanisms within each model, with particular attention to sex differences that may be exacerbated through methodological differences. Although searching for unified mechanisms is critical, we posit that effective treatment approaches are likely to leverage the heterogeneity presented by the tumor and pertinent biological variables to direct specific interventions. In exploring this heterogeneity, it becomes critical to consider methodological and data reporting approaches to best inform further research.

1 March 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
GLGrant R. Laskin
Grant R. Laskin
ACAna Regina Cabrera
Ana Regina Cabrera
NGNicholas P. Greene
Nicholas P. Greene
Robert J. TomkoRobert J. Tomko
Robert J. Tomko
CVCynthia Vied
Cynthia Vied
BGBradley S. Gordon
Bradley S. Gordon
We establish Arrdc2 as a novel mechanosensitive gene highly induced in response to mechanical unloading, particularly in aged muscle. Arrdc2 induction in C2C12 myotubes is sufficient to produce thinner myotubes and a transcriptional landscape consistent with muscle atrophy and disuse.

1 December 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
FMFrancielly Morena
Francielly Morena
ACAna Regina Cabrera
Ana Regina Cabrera
RJRonald G. Jones
Ronald G. Jones
ESEleanor R. Schrems
Eleanor R. Schrems
RMRuqaiza Muhyudin
Ruqaiza Muhyudin
NGNicholas P. Greene
Nicholas P. Greene
This study is among the first to integrate and compare the skeletal muscle transcriptional landscape across multiple preclinical models and biological sexes. We highlight that 1) early CC transcriptional changes are two-thirds conserved at late stages, 2) DEGs are largely model and sex specific, and 3) transcriptional factors including CLOCK and ARNTL/BMAL1, which influence early CC gene expression, might represent a global therapeutic target with a chance of efficacy across various cancer types.

27 October 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
ESEleanor Schrems
Eleanor Schrems
WHWesley S. Haynie
Wesley S. Haynie
RPRichard A. Perry
Richard A. Perry
FMFrancielly Morena
Francielly Morena
ACAna Regina Cabrera
Ana Regina Cabrera
TWTyrone Anthony Washington
Tyrone Anthony Washington
Cancer cachexia (CC) is a multifactorial wasting syndrome characterized by a significant loss in lean and/or fat mass and represents a leading cause of mortality in cancer patients. Nutraceutical treatments have been proposed as a potential treatment strategy to mitigate cachexia-induced muscle wasting. However, contradictory findings warrant further investigation. The purpose of this study was to determine the effects of leucine supplementation on skeletal muscle in male and female ApcMin/+ mice (APC). APC mice and their wild-type (WT) littermates were given normal drinking water or 1.5% leucine-supplemented water (n = 4–10/group/sex). We measured the gene expression of regulators of inflammation, protein balance, and myogenesis. Leucine treatment lowered survival rates, body mass, and muscle mass in males, while in females, it had no effect on body or muscle mass. Leucine treatment altered inflammatory gene expression by lowering Il1b 87% in the APC group and decreasing Tnfa 92% in both WT and APC males, while it had no effect in females (p < 0.05). Leucine had no effect on regulators of protein balance and myogenesis in either sex. We demonstrated that leucine exacerbates moribundity in males and is not sufficient for mitigating muscle or fat loss during CC in either sex in the ApcMin/+ mouse.